On September 17, 2024, Perceptive Advisors LLC made a significant new investment in the biotechnology sector by purchasing 8,194 shares of Instil Bio Inc (NASDAQ:TIL). The shares were acquired at a ...

After working in stealth since October, Perceptive Advisors is unveiling its latest biotech: LianBio, which serves the dual mission of bringing much-needed new drugs to China and helping U.S. biotech ...

Biopharma startups seeking a mix of financial, strategic and operational support gained a new option May 12 with the announcement of Perceptive Xontogeny Venture Fund II from Perceptive Advisors LLC.

Perceptive Advisors is moving into early-stage biotech investments in partnership with ex-Sarepta Therapeutics CEO Chris Garabedian. The $210 million fund began life by leading a $17 million series A ...